Epigenetics Podcast copertina

Epigenetics Podcast

Epigenetics Podcast

Di: Active Motif
Ascolta gratuitamente

Offerte di stagione | 0,99 €/mese per i primi 3 mesi

A seguire 9,99 €/mese – si applicano condizioni. Puoi disdire mensilmente.
A proposito di questo titolo
Discover the stories behind the science!Copyright 2020. All rights reserved. Scienza Scienze biologiche
  • Chromatin Architecture and Gene Regulation in T-Cell Leukemia (Francesco Boccalatte)
    Nov 12 2026

    In this episode of the Epigenetics Podcast, we talked with Francesco Boccalatte from the Genomic Architecture of Cancer lab at the Candiolo Cancer Institute in Turin about his work on chromatin architecture and gene regulation in T-cell leukemia.

    During his PhD, Boccalatte studied lentiviral gene therapy, stem cells, and microRNAs. He later joined the NYU lab of Iannis Aifantis, where he worked on stem-cell regulation and leukemia. Collaborations with computational scientists led him to study how chromatin structure relates to gene expression and leukemia cell identity, including through genome-wide Hi-C analyses.

    He explains how the team combined chromatin and gene-expression data, CRISPR experiments, computational predictions, and accessibility data to prioritize regulatory regions and transcription factors for further study. The work identified MIB as a factor that helps maintain certain chromatin structures; inhibiting it disrupted those structures and harmed cancer cells.

    Boccalatte’s lab now investigates why some patients with T-cell acute lymphoblastic leukemia do not respond to treatment or relapse early despite similar diagnoses and genetic profiles. The team is studying patient epigenomes and using machine learning to improve patient stratification and identify potential treatment directions. He closes by advising early-career scientists to stay curious, seek innovative approaches, and follow the questions that sustain their interest.

    References
    • Wang Q, Boccalatte F, Xu J, Gambi G, Nadorp B, Akter F, Mullin C, Melnick AF, Choe E, McCarter AC, Jerome NA, Chen S, Lin K, Khan S, Kodgule R, Sussman JH, Pölönen P, Rodriguez-Hernaez J, Narang S, Avrampou K, King B, Tsirigos A, Ryan RJH, Mullighan CG, Teachey DT, Tan K, Aifantis I, Chiang MY. Native stem cell transcriptional circuits define cardinal features of high-risk leukemia. J Exp Med. 2025 Apr 7;222(4):e20231349. doi: 10.1084/jem.20231349. Epub 2025 Feb 19. PMID: 39969525; PMCID: PMC11837855.
    • Gambi G, Boccalatte F, Rodriguez Hernaez J, Lin Z, Nadorp B, Polyzos A, Tan J, Avrampou K, Inghirami G, Kentsis A, Apostolou E, Aifantis I, Tsirigos A. 3D chromatin hubs as regulatory units of identity and survival in human acute leukemia. Mol Cell. 2025 Jan 2;85(1):42-60.e7. doi: 10.1016/j.molcel.2024.11.040. Epub 2024 Dec 23. PMID: 39719705; PMCID: PMC11934262.
    Related Episodes
    • Epigenetic Regulation and Small Molecule Innovation in AML: Advances in Translational Leukemia Research (Ani Deshpande)
    • MLL Proteins in Mixed-Lineage Leukemia (Yali Dou)
    • Hi-C and Three-Dimensional Genome Sequencing (Erez Lieberman Aiden)
    Contact
    • Epigenetics Podcast on Mastodon
    • Epigenetics Podcast on Bluesky
    • Dr. Stefan Dillinger on LinkedIn
    • Active Motif on LinkedIn
    • Active Motif on Bluesky
    • Email: podcast@activemotif.com
    Mostra di più Mostra meno
    42 min
  • DPPA2 and DPPA4 as Chromatin Priming Factors (Melanie Eckersley-Maslin)
    Oct 22 2026

    In this episode of the Epigenetics Podcast, we talked with Melanie Eckersley-Maslin from the Peter McCallum Cancer Center about her work on DPPA2 and DPPA4 as Chromatin Priming Factors.

    During her PhD in David Spector’s lab at Cold Spring Harbor Laboratory, Eckersley-Maslin studied monoallelic expression of autosomal genes. She developed an allele-specific RNA-sequencing screen to identify genes expressed differently from their two copies, then examined nuclear positioning, chromatin marks and DNA methylation. The work revealed associations between expression and chromatin state, but did not establish which changes caused the other.

    For her postdoctoral work in Wolf Reik’s lab in the UK, she investigated epigenetic regulation of zygotic genome activation, when an embryo begins transcribing its own genome. Using mouse embryonic stem cells that can enter a two-cell-like state, her research identified DPPA2 and DPPA4 as regulators of MERVL- and Zscan4-associated transcription. This work led her to consider how early-acting proteins may prime chromatin for later cell-fate decisions, even when their loss causes effects only much later in development.

    Then, Eckersley-Maslin discusses the importance of allowing researchers time to read, think and develop questions, as well as recognizing when to pause projects that are not progressing. She also describes moving from developmental biology into cancer research, bringing questions about cell identity and epigenetic regulation to a cancer-focused research environment.

    Her lab now studies DPPA2 and DPPA4 in cancer, including non-small-cell lung cancer. In that context, the proteins associate with chromatin domains marked by H3K4 trimethylation and H2AK119 ubiquitination, rather than the canonical bivalent combination studied in embryos. The function of these domains, including why they lack H3K27 trimethylation despite PRC2 recruitment, remains under investigation. She describes DPPA proteins as possible scaffolds that help recruit or coordinate chromatin machinery, rather than enzymes themselves.

    The conversation also covers sequential ChIP, which the lab refined to study the co-occurrence of histone modifications with limited cell numbers. Eckersley-Maslin notes that newer single-cell co-profiling methods may offer greater resolution. Looking ahead, her lab aims to identify other epigenetic priming factors and understand how chromatin states are established at particular genomic regions in particular cell types.

    References
    • Eckersley-Maslin MA, Thybert D, Bergmann JH, Marioni JC, Flicek P, Spector DL. Random monoallelic gene expression increases upon embryonic stem cell differentiation. Dev Cell. 2014 Feb 24;28(4):351-65. doi: 10.1016/j.devcel.2014.01.017. PMID: 24576421; PMCID: PMC3955261.
    • Eckersley-Maslin MA, Svensson V, Krueger C, Stubbs TM, Giehr P, Krueger F, Miragaia RJ, Kyriakopoulos C, Berrens RV, Milagre I, Walter J, Teichmann SA, Reik W. MERVL/Zscan4 Network Activation Results in Transient Genome-wide DNA Demethylation of mESCs. Cell Rep. 2016 Sep 27;17(1):179-192. doi: 10.1016/j.celrep.2016.08.087. PMID: 27681430; PMCID: PMC5055476.
    Related Episodes
    • The Role of lncRNAs in Tumor Growth and Treatment (Sarah Diermeier)
    • The Discovery of Genomic Imprinting (Azim Surani)
    • Epigenetic Reprogramming During Mammalian Development (Wolf Reik)
    Contact
    • Epigenetics Podcast on Mastodon
    • Epigenetics Podcast on Bluesky
    • Dr. Stefan Dillinger on LinkedIn
    • Active Motif on LinkedIn
    • Active Motif on Bluesky
    • Email: podcast@activemotif.com
    Mostra di più Mostra meno
    40 min
  • How Chromatin Marks Shape Transcription Factor Function (Luke Isbel)
    Oct 8 2026

    In this episode we speak with Luke Isbell, Senior Research Fellow and group leader at Adelaide University and the South Australian immunoGENomics Cancer Institute. We discuss his work on transcription factors, chromatin, and how epigenetic marks on histones can influence transcription factor binding and function, with a focus on p53 and chromatin-based ways its activity can be silenced in cancer cells.

    We also talk about how he became interested in biology, starting from growing up in rural Australia and later being introduced to epigenetics through Professor Emma Whitelaw. He describes how that experience shaped his path through honours and PhD training, and how his interest in biology developed into a long-term focus on chromatin and gene regulation.

    He explains his PhD work on mouse mutagenesis screens and the transcriptional repressor WIS, which was identified in a screen for genes with epigenetic function. We discuss how that work connected WIS to regulation of clustered genes in the brain and showed the value of forward genetic screening in mice.

    We then turn to his postdoctoral work in Switzerland with Dirk Schübeler, where he moved toward more mechanistic and reductionist chromatin biology. He describes the value of combining wet-lab and dry-lab work, and how that approach helps connect data generation with hypothesis testing.

    Finally, we discuss his current lab in Adelaide, where he studies p53 cofactors, transcription factors, and how cofactors may help interpret chromatin marks in a tissue-specific way. He also reflects on the use of AI in science and on the importance of critical thinking, and closes by emphasizing the need to be kinder to people in academia.

    References
    • Luke Isbel, Lexie Prokopuk, Haoyu Wu, Lucia Daxinger, Harald Oey, Alex Spurling, Adam J Lawther, Matthew W Hale, Emma Whitelaw (2016) Wiz binds active promoters and CTCF-binding sites and is required for normal behaviour in the mouse eLife 5:e15082. https://doi.org/10.7554/eLife.15082
    • Michael, A. K., Grand, R. S., Isbel, L., Cavadini, S., Kozicka, Z., Kempf, G., Bunker, R. D., Schenk, A. D., Graff-Meyer, A., Pathare, G. R., Weiss, J., Matsumoto, S., Burger, L., Schübeler, D., & Thomä, N. H. (2020). Mechanisms of OCT4-SOX2 motif readout on nucleosomes. Science, 368 (6498), 1460–1465. https://doi.org/10.1126/science.abb0074
    Related Episodes
    • Effects of DNA Methylation on Chromatin Structure and Transcription (Dirk Schübeler)
    • Pioneer Transcription Factors and Their Influence on Chromatin Structure (Ken Zaret)
    • The Impact of Sequence Variation on Transcription Factor Binding (Sven Heinz)
    Contact
    • Epigenetics Podcast on Mastodon
    • Epigenetics Podcast on Bluesky
    • Dr. Stefan Dillinger on LinkedIn
    • Active Motif on LinkedIn
    • Active Motif on Bluesky
    • Email: podcast@activemotif.com
    Mostra di più Mostra meno
    39 min
adbl_web_anon_alc_button_suppression_t1
Ancora nessuna recensione